CITY OF VACAVILLE APPROVES AXIOM POINT
VACAVILLE — Transwestern Ventures (TWV), in partnership with Transwestern Real Estate Services (TRS), announces that the City of Vacaville’s Planning Commission has approved plans to develop Axiom Point, a 375,000-square-foot, state-of-the-art biomanufacturing campus. The new development will be located on 22.4 acres in Vaca Valley Business Park at the interchange of I-80 and I-505. Axiom Point is the first life science campus to take advantage of the City’s Biotechnology and Advanced Manufacturing Initiative, which boasts a Biotechnology Fast-Track Program committing the City to processing Planning entitlements in 100 days or less.
“Vacaville has the land, infrastructure, and workforce that the biotechnology industry needs to grow, along with a long-standing commitment to a streamlined and frictionless process,” said City of Vacaville Mayor Ron Rowlett. “We are building on our proven success with the industry to secure Vacaville’s continued leadership as a biomanufacturing center going forward, and are fortunate that Transwestern sees the potential and value to investing in Vacaville. We look forward to the project getting underway.”
A development of Transwestern Ventures, Axiom Point will deliver in two phases, the first comprising 252,000 square feet and the second comprising 123,000 square feet. Designed for maximum flexibility, the project is ideal for occupier needs including biomanufacturing, laboratory research and development, medical device manufacturing, food science, agricultural technology and healthcare.
“We are excited to move forward with Axiom Point,” said Transwestern Managing Director Ken Meyersieck, who, along with Laboratory + Life Sciences experts Peter Conte and Andrew Wheeler, is handling leasing for the project. “The City of Vacaville has been a tremendous partner, providing excellent guidance and moving nimbly to approve the project. We are proud to offer this dynamic biomanufacturing campus in a region known for extraordinary talent and innovation.”
“Transwestern formally submitted our application in early September and we were approved by the Planning Commission less than 90 days later,” said Fred Knapp, Managing Partner of Transwestern Ventures. “That very impressive turnaround is a testament to the focus and commitment by the City of Vacaville to make biomanufacturing a cornerstone of its economic development plan.”
Due to its prime location, Vaca Valley Business Park has become home to life sciences companies such as Genentech, Johnson & Johnson, RxDNova, Agenus and Polaris.
